CONSTELLATION PHARMCETICLS I - COM (CNST)

CUSIP: 210373106

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
43,791,389
Share change
-9,727,351
Total reported value
$1,480,142,299
Put/Call ratio
268%
Price per share
$33.80
Number of holders
150
Value change
-$157,353,282
Number of buys
99
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 210373106?
CUSIP 210373106 identifies CNST - CONSTELLATION PHARMCETICLS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q2 2021

As of 30 Jun 2021, CONSTELLATION PHARMCETICLS I - COM (CNST) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,791,389 shares. The largest 10 holders included Avoro Capital Advisors LLC, BlackRock Inc., Column Group LLC, Ponoi Management, LLC, Magnetar Financial LLC, Omni Partners US LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), STATE STREET CORP, Versor Investments LP, and Ponoi II Management, LLC. This page lists 150 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.